Ocriplasmin (patient information): Difference between revisions

Latest revision as of 18:19, 26 February 2015

Redirect to:

Revision as of 18:16, 26 February 2015 (view source) Ammu Susheela (talk \| contribs) (Created page with "* In the days following JETREA administration, patients are at risk of developing intraocular inflammation/infection. Advise patients to seek immediate care from an ophthalmol...")		Latest revision as of 18:19, 26 February 2015 (view source) Ammu Susheela (talk \| contribs) (←Redirected page to Ocriplasmin#Patient Counseling Information)
Line 1:		Line 1:
	* In the days following JETREA administration, patients are at risk of developing intraocular inflammation/infection. Advise patients to seek immediate care from an ophthalmologist if the eye becomes red, sensitive to light, painful, or develops a change in vision.* Patients may experience temporary visual impairment after receiving an intravitreal injection of JETREA . Advise patients to not drive or operate heavy machinery until this visual impairment has resolved. If visual impairment persists or decreases further, advise patients to seek care from an ophthalmologist.		#REDIRECT[[Ocriplasmin#Patient Counseling Information]]